公司简介

EngeneIC is a biopharmaceutical company focused on developing its proprietary EDV? nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer. The EDV? is a first-in-class Cyto-Immunotherapy platform.

主要成员

Luigi Boschin

产品/服务

• 科技服务

EDV Technology

Targeted Drug Delivery

融资信息

融资轮次	融资日期	投资方	融资额度
Seed	2011-07	未披露	$1.02M
Series B	2015-01	GRT Capital Partners	$10M
Venture	2015-03	未披露	$7M
Venture	2015-07	未披露	$2.91M

关联公司